acut
respiratori
ill
ari
unconfirm
infecti
aetiolog
peak
differ
time
year
molecular
diagnost
assay
reduc
number
unconfirm
ari
compar
serologyor
culturebas
techniqu
screen
inpati
outpati
respiratori
specimen
span
late
autumn
earli
spring
identifi
presenc
human
coronaviru
hcov
occas
virus
specimen
respiratori
viru
detect
preval
peak
august
late
winter
southern
hemispher
detect
specimen
test
compris
hcov
detect
posit
specimen
use
develop
novel
revers
transcriptas
realtim
pcr
rtrtpcr
hcov
detect
object
clinic
sever
score
assign
posit
hcov
patient
sever
score
similar
random
select
young
children
posit
respiratori
syncyti
viru
differ
time
specimen
popul
cooler
month
sensit
specif
rtrtpcr
identifi
concurr
circul
four
hcov
quarter
cooccur
anoth
viru
children
age
two
year
acut
respiratori
ill
ari
frequent
caus
paediatr
morbid
common
reason
outpati
visit
hospitalis
among
children
rna
virus
frequent
caus
cold
influenzalik
ill
ili
usual
selflimit
upper
respiratori
tract
ill
urti
viru
detect
also
often
associ
lower
respiratori
tract
ill
lrti
although
replic
tissu
seldom
identifi
human
rhinovirus
hrv
respiratori
syncyti
viru
hrsv
influenzavirus
ifv
adenovirus
hadv
metapneumoviru
hmpv
parainfluenza
virus
hpiv
among
frequent
sought
respiratori
virus
clinic
microbiolog
laboratori
mani
peak
distinct
time
year
howev
even
bacteri
pathogen
ad
viral
panel
suspect
infect
remain
without
laboratori
confirm
inclus
virus
diagnost
algorithm
recommend
support
confirm
clinic
diagnos
infecti
aetiolog
nonetheless
extend
test
panel
often
use
research
project
human
coronavirus
hcov
one
group
pathogen
often
overlook
routin
test
two
envelop
posit
sens
rna
hcov
known
year
infect
two
virus
difficult
distinguish
ili
popul
vaccin
ifv
hcov
also
identifi
nonrespiratori
specimen
recent
three
new
hcov
detect
patient
ari
describ
sever
acut
respiratori
syndrom
coronaviru
sarscov
studi
note
genu
alphacoronaviru
speci
genu
betacoronaviru
speci
subspeci
may
circul
annual
preval
vari
significantli
seropreval
adult
reason
appar
reduc
exposur
may
relat
crossprotect
antibodi
effect
afford
prior
infect
rtpcr
method
frequent
detect
hcov
vitro
cultur
difficult
grow
without
sourc
primari
tissu
studi
definit
link
presenc
viral
rna
human
diseas
akin
conduct
use
infect
human
volunt
lack
hamper
assign
specif
diseas
associ
newli
identifi
respiratori
virus
screen
hcov
multiyear
popul
sampl
infrequ
studi
directli
compar
impact
hcov
infect
rare
despit
sizabl
histor
role
common
cold
hcov
also
found
patient
sever
case
ari
includ
lrti
pneumonia
adult
elderli
hcov
also
found
case
bronchial
hyperrespons
suscept
individu
nosocomi
respiratori
viral
infect
previous
identifi
instanc
sampl
collect
winter
expand
upon
investig
use
newli
design
revers
transcriptas
realtim
pcr
rtrtpcr
assay
screen
four
nonsarscov
hospitalbas
predominantli
paediatr
popul
ari
clinic
statu
patient
singl
multipl
hcov
detect
also
compar
expand
previou
studi
specimen
use
pcr
assay
screen
hcov
previous
identifi
panhcov
rtpcr
often
fail
detect
although
use
detect
therefor
includ
specif
assay
develop
rtrtpcr
detect
studi
enough
specimen
extract
remain
posit
confirm
use
nucleotid
sequenc
figur
newli
develop
rtrtpcr
confirm
previou
new
tabl
studi
convent
rtpcr
hcov
posit
previou
sequenc
region
confirm
hcov
ident
specimen
remain
rtrtpcr
produc
posit
result
defin
experiment
section
amplifi
clinic
sampl
posit
hrsv
n
hadv
n
hrv
n
ifv
n
hpivposit
n
specimen
hcov
rtrtpcr
sinc
use
sever
studi
includ
mani
posit
respiratori
virus
list
crossreact
note
analyt
sensit
assay
determin
copi
reaction
overal
instanc
coronaviru
test
specimen
detect
major
n
hcov
follow
n
n
n
hcov
detect
peak
late
winter
august
southern
hemispher
sampl
number
lowest
figur
hcov
detect
patient
two
year
old
less
children
age
year
compris
posit
patient
hcov
type
equal
distribut
male
femal
except
detect
male
p
confid
interv
detect
age
group
hcov
detect
neonat
n
detect
adult
virus
detect
patient
year
old
respiratori
viru
averag
age
posit
patient
highest
among
four
hcov
figur
tabl
hcov
involv
codetect
averag
level
codetect
studi
popul
tabl
frequent
respiratori
virus
sought
hrsv
hadv
hmpv
clinic
review
obtain
hcov
posit
repres
patient
hcov
detect
tabl
one
patient
codetect
sequenc
confirm
virus
present
data
shown
male
toddler
month
old
also
posit
hmpv
admit
three
month
prior
bronchiol
current
present
follow
seven
day
symptom
includ
cough
otiti
media
measur
fever
rhinorrhoea
salbutamol
antibiot
administ
averag
clinic
sever
score
among
patient
posit
hcov
case
hcovposit
review
admit
hospit
posit
hcov
admiss
remain
hour
sole
hcov
detect
differ
sever
score
four
hcov
group
either
sampl
singl
detect
codetect
consid
togeth
p
singl
detect
p
codetect
p
kruskalw
test
highest
averag
sever
score
observ
patient
also
posit
anoth
viru
hcov
case
met
gaunt
et
al
criteria
urti
n
lrti
n
tabl
data
could
obtain
four
hcovposit
case
antibiot
given
case
detect
whether
singl
codetect
often
made
patient
urti
lrti
figur
singl
detect
patient
chronic
diseas
detect
detect
accompani
anoth
viru
detect
made
chronic
diseas
immunocompromis
patient
number
hcov
detect
shown
left
bar
icimmunocompromis
lrtilow
respiratori
tract
ill
urtiupp
respiratori
tract
ill
commonli
note
addit
clinic
featur
among
patient
posit
hcov
n
hcov
case
cough
n
fever
n
vomit
n
tabl
among
hcov
codetect
common
featur
otiti
media
n
hcov
case
cough
n
fever
n
vomit
n
hcovposit
comparison
popul
hrsvposit
children
whose
chart
review
averag
sever
score
also
obviou
differ
hrsv
hcov
hospitalis
slightli
fewer
hrsv
case
admit
hcov
group
vs
hospitalis
time
shorter
vs
inpati
hour
fewer
patient
requir
mechan
ventil
vs
howev
hrsvposit
children
measur
fever
n
compar
hcovposit
patient
tabl
clinic
featur
patient
posit
hcov
studi
compris
respiratori
specimen
individu
present
queensland
hospit
sign
symptom
ari
may
septemb
includ
previous
describ
specimen
specimen
predominantli
nasopharyng
aspir
npa
collect
either
outpati
admit
patient
specimen
select
season
without
prior
knowledg
patient
detail
viral
diagnost
statu
subject
rang
age
three
day
year
mean
year
median
year
mode
year
infant
one
twelv
month
old
compris
studi
popul
prior
retrospect
studi
nucleic
acid
extract
specimen
test
common
respiratori
viral
pathogen
store
clinic
microbiolog
laboratori
assay
includ
cultureamplifi
direct
fluoresc
assay
subsequ
pcr
detect
hrsv
hadv
influenza
virus
b
ifav
ifbv
addit
pcr
assay
use
detect
hmpv
viru
detect
specimen
addit
rtrtpcr
test
human
rhinovirus
hrv
base
modifi
previous
describ
method
appli
hcovposit
sampl
rtpcr
use
initi
screen
specimen
includ
mix
convent
describ
previous
rtrtpcr
describ
studi
posit
patient
assay
subject
retrospect
medic
chart
review
posit
specimen
extract
remain
use
valid
newli
design
rtrtpcr
detect
singletarget
rtrtpcr
assay
develop
maximis
sensit
use
inhous
oligonucleotid
specif
tabl
reaction
mix
combin
purifi
rna
subject
rt
onestep
rtpcr
kit
qiagen
australia
min
follow
incub
pcr
perform
cycl
sec
sec
rotorgen
q
qiagen
australia
synthet
hcovspecif
vitro
transcrib
rna
ivtrna
creat
adapt
previous
describ
approach
use
oligonucleotid
bound
outsid
hcov
diagnost
rtrtpcr
target
area
oligonucleotid
tabl
rna
subject
two
treatment
dnase
turbo
life
technolog
follow
column
purif
high
pure
viral
nucleic
acid
kit
roch
diagnost
stock
rna
use
determin
analyt
sensit
assay
test
dilut
seri
last
dilut
yield
posit
result
defin
taken
limit
analyt
sensit
ivtrna
copi
number
calcul
use
optic
densiti
approxim
mass
rna
stock
solut
nm
determin
number
mole
establish
molecular
weight
hcovspecif
ivtrna
multipli
avogadro
number
posit
diagnost
result
defin
presenc
sigmoid
curv
cross
arbitrari
threshold
cycl
experi
duplic
nontempl
control
cross
threshold
nucleotid
sequenc
reaction
perform
use
amplicon
abi
bigdy
cycl
sequenc
kit
perkin
elmer
appli
biosystem
divis
usa
sequenc
determin
use
appli
biosystem
capillari
electrophoresi
genet
analys
nucleotid
sequenc
align
use
geneiou
pro
present
neighbourjoin
tree
prepar
mega
nucleotid
sequenc
deposit
genbank
result
studi
includ
medic
record
patient
specimen
posit
hcov
convent
rtpcr
review
determin
sever
ari
use
valid
object
score
system
sever
score
base
patient
need
hospitalis
supplement
fluid
degre
respiratori
support
clinic
inform
cough
wheez
fever
preexist
condit
document
also
record
secondari
dataset
clinic
inform
n
also
collect
agematch
patient
less
three
year
age
posit
hrsv
also
present
ari
juli
decemb
retrospect
investig
australian
paediatr
hospitalbas
winter
popul
presenc
hcov
develop
four
novel
rtrtpcr
studi
identifi
cocircul
four
nonsarscov
uncommon
pauciti
data
hinder
direct
comparison
epidemiolog
clinic
featur
individu
infect
differ
hcov
assay
design
detect
four
hcov
insensit
practic
use
clinic
microbiolog
laboratori
other
use
similar
measur
assay
sensit
employ
proven
sensit
specif
use
screen
focus
hospit
diseas
popul
appear
commerci
assay
altern
progress
larg
scale
routin
use
rare
incid
sampl
higher
report
threeyear
studi
preval
among
hospit
pneumonia
ari
andor
fever
reflect
focus
winter
studi
period
mix
inpati
outpati
hospit
popul
known
period
peak
hcov
preval
similar
other
observ
high
number
codetect
among
hcov
compar
overal
studi
popul
other
comment
hcov
impart
limit
impact
due
low
preval
rel
higher
proport
involv
codetect
low
secondari
attack
rate
household
retrospect
studi
also
observ
clinic
featur
averag
sever
score
patient
hcov
close
similarli
age
set
children
posit
hrsv
detect
patient
rang
clinic
condit
predomin
among
chronic
condit
manifest
urti
lrti
domin
detect
overal
specif
urti
lrti
vomit
cough
fever
otiti
media
find
similar
hong
kong
previous
identifi
patient
pneumonia
associ
fever
febril
convuls
howev
whether
singl
codetect
lowest
averag
sever
score
metric
focuss
respiratori
symptom
dijkman
et
al
propos
seroconvers
domin
domin
crossprotect
neutral
antibodi
elicit
first
infect
studi
found
detect
peak
august
made
detect
peak
juli
although
number
winter
studi
smaller
dijkman
et
al
differ
peak
detect
great
test
inpati
outpati
sampl
queensland
hospit
present
may
septemb
may
better
resolv
reflect
hcov
activ
outcom
fiveyear
averag
test
result
paediatr
inpati
age
two
year
extend
serosurvey
popul
may
resolv
discrep
neither
occur
patient
rash
immunocompromis
diarrhoea
vomit
chronic
diseas
common
among
cough
includ
croup
prolong
cough
lrti
keep
associ
croup
vomit
diarrhoea
occur
often
case
support
recent
find
hcov
sever
studi
limit
highlight
popul
repres
clinic
well
subject
ie
feel
ill
enough
warrant
visit
hospit
outpati
clinic
conclus
impact
virus
commun
drawn
beyond
extrapol
patient
popul
sampl
commun
reason
assum
virus
circul
concurr
addit
worth
note
respiratori
virus
far
found
extent
clinic
well
popul
find
bestow
unimport
reduc
pathogen
upon
virus
statist
signific
higher
proport
number
detect
ill
popul
versu
control
group
guarante
causal
upon
viru
human
immun
play
signific
regulatori
role
everi
viru
challeng
control
popul
first
mani
step
identifi
diseas
associ
anoth
use
step
birth
cohort
follow
sever
year
sampl
regular
short
interv
regardless
diseas
state
cohort
underway
crosssect
studi
could
defin
happen
hcov
offseason
test
specimen
bocavirus
hrv
overal
number
codetect
may
underreport
expect
predomin
male
among
case
pattern
gender
distribut
differ
hcov
possibl
type
error
associ
multipl
test
howev
four
test
small
pvalu
possibl
indic
true
viru
effect
requir
investig
confirm
frequent
detect
hcov
involv
broadest
array
clinic
outcom
consid
diagnosi
acut
adult
respiratori
diseas
may
play
role
sever
diseas
involv
multipl
virus
occur
infrequ
mostli
codetect
role
ari
beyond
common
cold
remain
hard
defin
despit
report
role
ari
immunocompromis
patient
mani
case
immunocompromis
popul
may
miss
role
studi
present
design
applic
four
sensit
specif
novel
rtrtpcr
allow
us
differenti
peak
hcov
preval
circul
respiratori
virus
observ
hcovspecif
differ
codetect
frequenc
monthli
peak
preval
sex
posit
patient
even
though
mani
differ
note
crosssect
studi
futur
respiratori
viru
studi
need
confirm
better
defin
differ
frequent
analysi
cohorte
andor
studi
conduct
greater
period
time
prospect
cohort
studi
improv
understand
biolog
virus
ultim
improv
patient
care
better
defin
discord
test
method
studi
time
popul
characterist
